The role of nonspecific immunotherapy in the treatment of breast cancer.
D001859:Bone Neoplasms / Q000628:therapy; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007167:Immunotherapy; D008113:Liver Neoplasms / Q000628:therapy; D008175:Lung Neoplasms / Q000628:therapy; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D011379:Prognosis; D011425:Propionibacterium acnes / Q000276:immunology
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate